Kersti Oselin
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Drug Transport and Resistance Mechanisms
- Lung Cancer Research Studies
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 15
- Cancer Immunotherapy and Biomarkers 7
- Drug Transport and Resistance Mechanisms 4
-
- Lung Cancer Diagnosis and Treatment 8
- Lung Cancer Treatments and Mutations 7
- Co-authors
- Ivar Roots (5 shared papers)Przemysław Michał Mrozikiewicz (4 shared papers)Thomas Gerloff (2 shared papers)Rein Pähkla (4 shared papers)Kaili Anier (5 shared papers)Tuuli Metsvaht (9 shared papers)Irja Lutsar (7 shared papers)Karin Kipper (8 shared papers)
- Journals
- Annals of Oncology (4 papers)Antimicrobial Agents and Chemotherapy (3 papers)European Journal of Clinical Pharmacology (2 papers)Journal of Thoracic Oncology (2 papers)British Journal of Clinical Pharmacology (1 paper)
- Partner nations
- EstoniaGermanyUnited Kingdom
In The Last Decade
Kersti Oselin
40 papers receiving 1.3k citations
Kersti Oselin's Hit Papers
Peers
Comparison fields: 5 of 82
- Oncology 599
- Pulmonary and Respiratory Medicine 383
- Pharmacology 163
- Pediatrics, Perinatology and Child Health 180
- Applied Microbiology and Biotechnology 17
Countries citing papers authored by Kersti Oselin
This map shows the geographic impact of Kersti Oselin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kersti Oselin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kersti Oselin more than expected).
Fields of papers citing papers by Kersti Oselin
This network shows the impact of papers produced by Kersti Oselin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kersti Oselin. The network helps show where Kersti Oselin may publish in the future.
Co-authors
The 25 scholars most cited alongside Kersti Oselin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB–IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial Hit paper breakdown → | 2022 | 531 |
| 2 | 2002 | 129 | |
| 3 | 2007 | 65 | |
| 4 | 2003 | 60 | |
| 5 | 2022 | 58 | |
| 6 | 2003 | 47 | |
| 7 | 2012 | 45 | |
| 8 | 2003 | 34 | |
| 9 | 2016 | 34 | |
| 10 | 2003 | 33 | |
| 11 | 2021 | 31 | |
| 12 | 2007 | 23 | |
| 13 | 2003 | 21 | |
| 14 | 2018 | 21 | |
| 15 | 2007 | 19 | |
| 16 | 2008 | 18 | |
| 17 | 2015 | 16 | |
| 18 | 2006 | 14 | |
| 19 | 2019 | 14 | |
| 20 | 2009 | 13 |
About Kersti Oselin
Kersti Oselin is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pharmacology, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health, having authored 43 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (8 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers), Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Treatments and Mutations (7 papers), Drug Transport and Resistance Mechanisms (4 papers), Cancer Genomics and Diagnostics (3 papers), Acute Lymphoblastic Leukemia research (3 papers) and Neonatal and Maternal Infections (2 papers). The work is most often cited by research in Oncology (599 citations), Pulmonary and Respiratory Medicine (383 citations), Pharmacology (163 citations), Pediatrics, Perinatology and Child Health (180 citations) and Applied Microbiology and Biotechnology (17 citations). Kersti Oselin has collaborated with scholars based in Estonia, Germany and United Kingdom. Frequent co-authors include Ivar Roots, Przemysław Michał Mrozikiewicz, Thomas Gerloff, Rein Pähkla, Kaili Anier, Tuuli Metsvaht, Irja Lutsar, Karin Kipper, Andreas Johne and Christian Meisel. Their work appears in journals such as Annals of Oncology, Antimicrobial Agents and Chemotherapy, European Journal of Clinical Pharmacology, Journal of Thoracic Oncology and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.